1. (−)Epigallocatechin-3-gallate prevents the reserpine-induced impairment of short-term social memory in rats. Issue 8 (December 2015) Journal: Behavioural pharmacology Issue: Volume 26:Issue 8(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. (−)Epigallocatechin-3-gallate prevents the reserpine-induced impairment of short-term social memory in rats. Issue 8 (December 2015) Authors: Tseng, Hsiang-Chien; Wang, Mao-Hsien; Soung, Hung-Sheng; Chang, Yi; Chang, Kuo-Chi Journal: Behavioural pharmacology Issue: Volume 26:Issue 8(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2, 3, 5, 4′-Tetrahydroxystilbene-2-O-β-D-glucoside prevention of lipopolysaccharide-induced depressive-like behaviors in mice involves neuroinflammation and oxido-nitrosative stress inhibition. Issue 5 (August 2017) Authors: Chen, Zhuo; Huang, Chao; He, Haiyan; Ding, Wenbin Journal: Behavioural pharmacology Issue: Volume 28:Issue 5(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 5-(4-Hydroxy-3-dimethoxybenzylidene)-thiazolidinone improves motor functions and exerts antioxidant potential in hemiparkinsonian rats. Issue 1 (30th November 2022) Authors: Ren, Zhili; Ding, Hui; Zhou, Ming; Yang, Nan; Liu, Yanyong; Chan, Piu Journal: Behavioural pharmacology Issue: Volume 34:Issue 1(2023) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 5-HT1A receptor-dependent control of nigrostriatal dopamine neurotransmission in the pharmacotherapy of Parkinson's disease and schizophrenia. Issue 1 (February 2015) Authors: Haleem, Darakhshan J. Journal: Behavioural pharmacology Issue: Volume 26:Issue 1/2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 5-HT1A receptor-dependent control of nigrostriatal dopamine neurotransmission in the pharmacotherapy of Parkinson's disease and schizophrenia. Issue 1 (February 2015) Authors: Haleem, Darakhshan J. Journal: Behavioural pharmacology Issue: Volume 26:Issue 1/2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 5-HT2A and mGlu2/3 receptor interactions: on their relevance to cognitive function and psychosis. Issue 1 (February 2016) Authors: Wischhof, Lena; Koch, Michael Journal: Behavioural pharmacology Issue: Volume 27:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 5-HT2A and mGlu2/3 receptor interactions: on their relevance to cognitive function and psychosis. Issue 1 (February 2016) Authors: Wischhof, Lena; Koch, Michael Journal: Behavioural pharmacology Issue: Volume 27:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. [INCREMENT]9-Tetrahydrocannabinol discriminative stimulus effects of AM2201 and related aminoalkylindole analogs in rats. Issue 2 (April 2016) Authors: Järbe, Torbjörn U.C.; Gifford, Roger S.; Zvonok, Alexander; Makriyannis, Alexandros Journal: Behavioural pharmacology Issue: Volume 27:Issue 2/3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A behavioral economic analysis of the value-enhancing effects of nicotine and varenicline and the role of nicotinic acetylcholine receptors in male and female rats. Issue 6 (September 2018) Authors: Barrett, Scott T.; Geary, Trevor N.; Steiner, Amy N.; Bevins, Rick A. Journal: Behavioural pharmacology Issue: Volume 29:Issue 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗